Accordingly, patients with IDH mutant gliomas who harbored at least one of the abovementioned CNAs had a significantly worse prognosis than did patients with IDH mutant gliomas without these CNAs (p < 0.0001; Fig 1E and 1F). The gene discussed is IDH2; the disease is glioma.